{"id":11976,"date":"2025-07-01T13:03:50","date_gmt":"2025-07-01T11:03:50","guid":{"rendered":"https:\/\/www.kliinikum.ee\/yhendlabor\/?page_id=11976"},"modified":"2025-11-26T18:08:41","modified_gmt":"2025-11-26T16:08:41","slug":"hla-klass-i-ja-ii-antikehad-s-hla-class-i-ii-ab","status":"publish","type":"page","link":"https:\/\/www.kliinikum.ee\/yhendlabor\/kasiraamat\/hla-ja-koesobivusuuringud\/hla-klass-i-ja-ii-antikehad-s-hla-class-i-ii-ab\/","title":{"rendered":"HLA klass I ja II antikehad (S-HLA class I, II Ab)"},"content":{"rendered":"\n<p><em>Immuunanal\u00fc\u00fcsi osakond<\/em><\/p>\n\n\n\n<p class=\"has-medium-font-size\"><strong>Anal\u00fc\u00fcsid:<\/strong><\/p>\n\n\n\n<figure class=\"wp-block-table is-style-stripes\"><table width=\"100%\"><tbody><tr><td width=\"1%\"><\/td><td width=\"99%\">HLA Ab s\u00f5eluuringu paneel (xMAP)<\/td><\/tr><tr><td><\/td><td>HLA klass I Ab identifitseerimine (xMAP)<\/td><\/tr><tr><td><\/td><td>HLA klass II Ab identifitseerimine (xMAP)<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p>Koesobivus on m\u00e4\u00e4ratud MHC (<em>major histocompatibility complex<\/em>) geenide poolt, mis paiknevad 6. kromosoomi l\u00fchikeses \u00f5las. Inimese koesobivuse geene nimetatakse <strong>HLA (<em>human leucocyte antigens<\/em>) <\/strong>geenideks. MHC I regiooni kuuluvad HLA-A, HLA-B, HLA-C geenid, MHC II regiooni kuuluvad HLA-DR, -DQ ja -DP geenid.<\/p>\n\n\n\n<p>M\u00f5ningatel juhtudel (rasedused, vere\u00fclekanded, siirdamised) v\u00f5ivad tekkida antikehad teatud HLA antigeenide vastu. Doonorspetsiifiliste antikehade esinemine v\u00f5ib viia siirdamisj\u00e4rgse \u00e4rat\u00f5ukereaktsioonini.<\/p>\n\n\n\n<p>Enne elundisiirdamise ootelehele v\u00f5tmist tehakse kindlaks, kas patsiendil esineb HLA antigeenide vastaseid antikehi. Kuna sensibilisatsiooni tase v\u00f5ib ajas muutuda, on oluline antikehade regulaarne m\u00e4\u00e4ramine. Elundisiirdamise ootelehele registreeritud patsiendil teostatakse anal\u00fc\u00fcs \u00fcks kord kvartalis, lisaks 14 ja 28 p\u00e4eva p\u00e4rast v\u00f5imalikku sensibiliseerivat juhtu. Saadud tulemusi arvestatakse doonorelundi valikul.<\/p>\n\n\n\n<p>Siirdamise j\u00e4rgsel perioodil on &nbsp;HLA-vastaste antikehade m\u00e4\u00e4ramine n\u00e4idustatud j\u00e4rgnevatel juhtudel: doonorspetsiifiliste antikehade esinemine siirdamise hetkel\/ajalooliselt, kahtlus siiriku \u00e4rat\u00f5ukele, oluline muutus immuunsupressiivses ravis, kahtlus ravidistsipliini rikkumisele, protokoll-biopsia.<\/p>\n\n\n\n<p class=\"has-medium-font-size\"><strong>Uuritav materjal, selle v\u00f5tmine, saatmine ja s\u00e4ilitamine<\/strong><\/p>\n\n\n\n<figure class=\"wp-block-table is-style-stripes\"><table width=\"100%\"><tbody><tr><td width=\"1%\"><\/td><td width=\"20%\"><strong>Katsuti<\/strong><\/td><td width=\"79%\">Geeli ja h\u00fc\u00fcbimisaktivaatoriga katsuti (punane kollase r\u00f5ngaga v\u00f5i kollane kork)<\/td><\/tr><tr><td><\/td><td><strong>Anal\u00fc\u00fcsitav kogus<\/strong><\/td><td>5 mL seerumit<\/td><\/tr><tr><td><\/td><td><strong>S\u00e4ilivus<\/strong><\/td><td>Seerum +4 \u00b0C 48 tundi, -20 \u00b0C \u00fcks kuu<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p class=\"has-medium-font-size\"><strong>Anal\u00fc\u00fcsi tegemise aeg:<\/strong> vastavalt vajadusele<\/p>\n\n\n\n<p class=\"has-medium-font-size\"><strong>Anal\u00fc\u00fcsimeetod<\/strong><\/p>\n\n\n\n<p>HLA klass I ja II vastaste IgG t\u00fc\u00fcpi antikehade olemasolu ja hulga hindamine ning antikehade spetsiifika m\u00e4\u00e4ramine xMAP meetodil anal\u00fcsaatoril Luminex.<\/p>\n\n\n\n<p class=\"has-medium-font-size\"><strong>Vastuse vorm<\/strong><\/p>\n\n\n\n<p>Negatiivne\/positiivne; positiivse tulemuse korral antikehade spetsiifika m\u00e4\u00e4ramine.<\/p>\n\n\n\n<p class=\"has-medium-font-size\"><strong>N\u00e4idustus<\/strong><\/p>\n\n\n\n<p>Elundisiirdamise eel ja selle j\u00e4rgselt retsipiendi immunoloogilise riski hindamine. Konkreetse retsipiendi jaoks sobimatute HLA antigeenide tuvastamine.<\/p>\n\n\n\n<p>Vt ka: <a href=\"https:\/\/www.kliinikum.ee\/yhendlabor\/kasiraamat\/hla-ja-koesobivusuuringud\/hla-alleelide-maaramine-koesobivuse-hindamiseks\/\">HLA alleelide m\u00e4\u00e4ramine koesobivuse hindamiseks<\/a><br><a href=\"https:\/\/www.kliinikum.ee\/yhendlabor\/kasiraamat\/hla-ja-koesobivusuuringud\/ristsobivustest-b-s-xm\/\">Ristsobivustest<br><\/a>JKL-225 \u201eKoesobivusanal\u00fc\u00fcside teostamine neeru, pankrease, kombineeritud neeru-pankrease ja maksa siirdamisel\u201c<br>JKL-226 \u201eKoesobivusanal\u00fc\u00fcside teostamine rindkereorganite siirdamisel\u201c<\/p>\n\n\n\n<p>Koostajad: Astra V\u00e4strik, Kaie Lokk<br>Muudetud 26.01.24<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Immuunanal\u00fc\u00fcsi osakond Anal\u00fc\u00fcsid: HLA Ab s\u00f5eluuringu paneel (xMAP) HLA klass I Ab identifitseerimine (xMAP) HLA klass II Ab identifitseerimine (xMAP) Koesobivus on m\u00e4\u00e4ratud MHC (major histocompatibility complex) geenide poolt, mis paiknevad 6. kromosoomi l\u00fchikeses \u00f5las. Inimese koesobivuse geene nimetatakse HLA (human leucocyte antigens) geenideks. MHC I regiooni kuuluvad HLA-A, HLA-B, HLA-C geenid, MHC II regiooni [&hellip;]<\/p>\n","protected":false},"author":38,"featured_media":0,"parent":7268,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_uag_custom_page_level_css":"","footnotes":""},"class_list":["post-11976","page","type-page","status-publish","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>HLA klass I ja II antikehad (S-HLA class I, II Ab) - \u00dchendlabor<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.kliinikum.ee\/yhendlabor\/kasiraamat\/hla-ja-koesobivusuuringud\/hla-klass-i-ja-ii-antikehad-s-hla-class-i-ii-ab\/\" \/>\n<meta property=\"og:locale\" content=\"et_EE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"HLA klass I ja II antikehad (S-HLA class I, II Ab) - \u00dchendlabor\" \/>\n<meta property=\"og:description\" content=\"Immuunanal\u00fc\u00fcsi osakond Anal\u00fc\u00fcsid: HLA Ab s\u00f5eluuringu paneel (xMAP) HLA klass I Ab identifitseerimine (xMAP) HLA klass II Ab identifitseerimine (xMAP) Koesobivus on m\u00e4\u00e4ratud MHC (major histocompatibility complex) geenide poolt, mis paiknevad 6. kromosoomi l\u00fchikeses \u00f5las. Inimese koesobivuse geene nimetatakse HLA (human leucocyte antigens) geenideks. MHC I regiooni kuuluvad HLA-A, HLA-B, HLA-C geenid, MHC II regiooni [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.kliinikum.ee\/yhendlabor\/kasiraamat\/hla-ja-koesobivusuuringud\/hla-klass-i-ja-ii-antikehad-s-hla-class-i-ii-ab\/\" \/>\n<meta property=\"og:site_name\" content=\"\u00dchendlabor\" \/>\n<meta property=\"article:modified_time\" content=\"2025-11-26T16:08:41+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutit\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.kliinikum.ee\\\/yhendlabor\\\/kasiraamat\\\/hla-ja-koesobivusuuringud\\\/hla-klass-i-ja-ii-antikehad-s-hla-class-i-ii-ab\\\/\",\"url\":\"https:\\\/\\\/www.kliinikum.ee\\\/yhendlabor\\\/kasiraamat\\\/hla-ja-koesobivusuuringud\\\/hla-klass-i-ja-ii-antikehad-s-hla-class-i-ii-ab\\\/\",\"name\":\"HLA klass I ja II antikehad (S-HLA class I, II Ab) - \u00dchendlabor\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.kliinikum.ee\\\/yhendlabor\\\/#website\"},\"datePublished\":\"2025-07-01T11:03:50+00:00\",\"dateModified\":\"2025-11-26T16:08:41+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.kliinikum.ee\\\/yhendlabor\\\/kasiraamat\\\/hla-ja-koesobivusuuringud\\\/hla-klass-i-ja-ii-antikehad-s-hla-class-i-ii-ab\\\/#breadcrumb\"},\"inLanguage\":\"et\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.kliinikum.ee\\\/yhendlabor\\\/kasiraamat\\\/hla-ja-koesobivusuuringud\\\/hla-klass-i-ja-ii-antikehad-s-hla-class-i-ii-ab\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.kliinikum.ee\\\/yhendlabor\\\/kasiraamat\\\/hla-ja-koesobivusuuringud\\\/hla-klass-i-ja-ii-antikehad-s-hla-class-i-ii-ab\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.kliinikum.ee\\\/yhendlabor\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"K\u00e4siraamat\",\"item\":\"https:\\\/\\\/www.kliinikum.ee\\\/yhendlabor\\\/kasiraamat\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"HLA ja koesobivusuuringud\",\"item\":\"https:\\\/\\\/www.kliinikum.ee\\\/yhendlabor\\\/kasiraamat\\\/hla-ja-koesobivusuuringud\\\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"HLA klass I ja II antikehad (S-HLA class I, II Ab)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.kliinikum.ee\\\/yhendlabor\\\/#website\",\"url\":\"https:\\\/\\\/www.kliinikum.ee\\\/yhendlabor\\\/\",\"name\":\"\u00dchendlabor\",\"description\":\"Hoolivus, Uuendusmeelsus, P\u00e4devus ja Usaldusv\u00e4\u00e4rsus\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.kliinikum.ee\\\/yhendlabor\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"et\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"HLA klass I ja II antikehad (S-HLA class I, II Ab) - \u00dchendlabor","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.kliinikum.ee\/yhendlabor\/kasiraamat\/hla-ja-koesobivusuuringud\/hla-klass-i-ja-ii-antikehad-s-hla-class-i-ii-ab\/","og_locale":"et_EE","og_type":"article","og_title":"HLA klass I ja II antikehad (S-HLA class I, II Ab) - \u00dchendlabor","og_description":"Immuunanal\u00fc\u00fcsi osakond Anal\u00fc\u00fcsid: HLA Ab s\u00f5eluuringu paneel (xMAP) HLA klass I Ab identifitseerimine (xMAP) HLA klass II Ab identifitseerimine (xMAP) Koesobivus on m\u00e4\u00e4ratud MHC (major histocompatibility complex) geenide poolt, mis paiknevad 6. kromosoomi l\u00fchikeses \u00f5las. Inimese koesobivuse geene nimetatakse HLA (human leucocyte antigens) geenideks. MHC I regiooni kuuluvad HLA-A, HLA-B, HLA-C geenid, MHC II regiooni [&hellip;]","og_url":"https:\/\/www.kliinikum.ee\/yhendlabor\/kasiraamat\/hla-ja-koesobivusuuringud\/hla-klass-i-ja-ii-antikehad-s-hla-class-i-ii-ab\/","og_site_name":"\u00dchendlabor","article_modified_time":"2025-11-26T16:08:41+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"2 minutit"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.kliinikum.ee\/yhendlabor\/kasiraamat\/hla-ja-koesobivusuuringud\/hla-klass-i-ja-ii-antikehad-s-hla-class-i-ii-ab\/","url":"https:\/\/www.kliinikum.ee\/yhendlabor\/kasiraamat\/hla-ja-koesobivusuuringud\/hla-klass-i-ja-ii-antikehad-s-hla-class-i-ii-ab\/","name":"HLA klass I ja II antikehad (S-HLA class I, II Ab) - \u00dchendlabor","isPartOf":{"@id":"https:\/\/www.kliinikum.ee\/yhendlabor\/#website"},"datePublished":"2025-07-01T11:03:50+00:00","dateModified":"2025-11-26T16:08:41+00:00","breadcrumb":{"@id":"https:\/\/www.kliinikum.ee\/yhendlabor\/kasiraamat\/hla-ja-koesobivusuuringud\/hla-klass-i-ja-ii-antikehad-s-hla-class-i-ii-ab\/#breadcrumb"},"inLanguage":"et","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.kliinikum.ee\/yhendlabor\/kasiraamat\/hla-ja-koesobivusuuringud\/hla-klass-i-ja-ii-antikehad-s-hla-class-i-ii-ab\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.kliinikum.ee\/yhendlabor\/kasiraamat\/hla-ja-koesobivusuuringud\/hla-klass-i-ja-ii-antikehad-s-hla-class-i-ii-ab\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.kliinikum.ee\/yhendlabor\/"},{"@type":"ListItem","position":2,"name":"K\u00e4siraamat","item":"https:\/\/www.kliinikum.ee\/yhendlabor\/kasiraamat\/"},{"@type":"ListItem","position":3,"name":"HLA ja koesobivusuuringud","item":"https:\/\/www.kliinikum.ee\/yhendlabor\/kasiraamat\/hla-ja-koesobivusuuringud\/"},{"@type":"ListItem","position":4,"name":"HLA klass I ja II antikehad (S-HLA class I, II Ab)"}]},{"@type":"WebSite","@id":"https:\/\/www.kliinikum.ee\/yhendlabor\/#website","url":"https:\/\/www.kliinikum.ee\/yhendlabor\/","name":"\u00dchendlabor","description":"Hoolivus, Uuendusmeelsus, P\u00e4devus ja Usaldusv\u00e4\u00e4rsus","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.kliinikum.ee\/yhendlabor\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"et"}]}},"uagb_featured_image_src":{"full":false,"thumbnail":false,"medium":false,"medium_large":false,"large":false,"1536x1536":false,"2048x2048":false},"uagb_author_info":{"display_name":"Kadi Siigur","author_link":"https:\/\/www.kliinikum.ee\/yhendlabor\/author\/kadisi\/"},"uagb_comment_info":0,"uagb_excerpt":"Immuunanal\u00fc\u00fcsi osakond Anal\u00fc\u00fcsid: HLA Ab s\u00f5eluuringu paneel (xMAP) HLA klass I Ab identifitseerimine (xMAP) HLA klass II Ab identifitseerimine (xMAP) Koesobivus on m\u00e4\u00e4ratud MHC (major histocompatibility complex) geenide poolt, mis paiknevad 6. kromosoomi l\u00fchikeses \u00f5las. Inimese koesobivuse geene nimetatakse HLA (human leucocyte antigens) geenideks. MHC I regiooni kuuluvad HLA-A, HLA-B, HLA-C geenid, MHC II regiooni&hellip;","_links":{"self":[{"href":"https:\/\/www.kliinikum.ee\/yhendlabor\/wp-json\/wp\/v2\/pages\/11976","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.kliinikum.ee\/yhendlabor\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.kliinikum.ee\/yhendlabor\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.kliinikum.ee\/yhendlabor\/wp-json\/wp\/v2\/users\/38"}],"replies":[{"embeddable":true,"href":"https:\/\/www.kliinikum.ee\/yhendlabor\/wp-json\/wp\/v2\/comments?post=11976"}],"version-history":[{"count":0,"href":"https:\/\/www.kliinikum.ee\/yhendlabor\/wp-json\/wp\/v2\/pages\/11976\/revisions"}],"up":[{"embeddable":true,"href":"https:\/\/www.kliinikum.ee\/yhendlabor\/wp-json\/wp\/v2\/pages\/7268"}],"wp:attachment":[{"href":"https:\/\/www.kliinikum.ee\/yhendlabor\/wp-json\/wp\/v2\/media?parent=11976"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}